| Dr Mitchell S Finkel, M D | |
|
1 Stadium Drive, Morgantown, WV 26506 | |
| (304) 598-4800 | |
| Not Available |
| Full Name | Dr Mitchell S Finkel |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Cardiovascular Disease |
| Location | 1 Stadium Drive, Morgantown, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144333899 | NPI | - | NPPES |
| 0086449000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 18491 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mitchell S Finkel, M D P. O. Box 897, Morgantown, WV 26507-0897 Ph: (304) 293-7401 | Dr Mitchell S Finkel, M D 1 Stadium Drive, Morgantown, WV 26506 Ph: (304) 598-4800 |
News Archive
Anthem Blue Cross and Blue Shield in Nevada, together with its agency, Deutsch LA, received a 2010 CLIO Healthcare Award for its "Our Health Connects Us" campaign. The bronze level award in the Integrated Campaign category was presented on November 12th at a ceremony in New York City.
Science Applications International Corporation (SAIC) announced today it was awarded a contract by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to provide preclinical services for the development of biopharmaceutical products for infectious diseases.
Adding "chemical shift" techniques to MRI can help differentiate clear cell renal cell carcinoma from other types of renal cell cancer, a new study shows. That differentiation can help physicians better determine treatment for these patients.
Sorin Group announced today the first inclusion of a patient in the Clepsydra clinical trial. The study will investigate the sensitivity to changes in heart failure status of PhD™, a unique diagnostic feature using the dual sensor technology of minute ventilation and accelerometer to monitor patient's breathing and activity levels every day.
The most common treatments for cancer are radiation and chemotherapy. However they have side effects and also damage healthy tissues. Moreover, their effectiveness is limited when the cancer has spread through out the body. Researchers at the Niels Bohr Institute are therefore working to develop a gentler treatment that 'tricks' the cancer cells, which would absorb a cytotoxin and therefore be destroyed, while healthy cells would remain unaffected. The results are published in the scientific journal, Scientific Reports.
› Verified 7 days ago
Rohma Shamsi, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1 Medical Center Drive, Morgantown, WV 26506 Phone: 304-293-4125 | |
Islam Younes, Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 855-988-2273 | |
Dr. David Weissman, M. D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1 Stadium Drive, Morgantown, WV 26506 Phone: 304-598-4800 Fax: 304-293-6963 | |
Dr. Madhavi Kadiyala, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-598-4000 | |
Dr. Swapna Gayam, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Drive, Morgantown, WV 26506 Phone: 304-293-4123 Fax: 304-293-2135 | |
Monika Maximilliane Holbein, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 304-594-4000 | |
Nour Daboul, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Center Dr, Morgantown, WV 26506 Phone: 855-988-2273 |